Age
stringclasses 73
values | Date of Data Entry
stringlengths 4
19
| Gender
stringclasses 3
values | Diagnosis
stringlengths 3
81
| Name of Drug
stringclasses 57
values | Dosage (gram)
stringclasses 28
values | Route
stringclasses 4
values | Frequency
stringclasses 6
values | Duration (days)
stringclasses 15
values | Indication
stringlengths 1
53
⌀ |
|---|---|---|---|---|---|---|---|---|---|
70 | 19/12/2019 14:53:11 | Male | septic shock, miliary tb, cerebral infarct, herpes encephalitis | meropenem | 0.5 | IV | BD | 2 | miliary tb |
70 | 19/12/2019 14:54:47 | Male | septic shock, miliary tb, cerebral infarct, herpes encephalitis | septrin | 0.48 | Oral | OD | 1 | miliary tb |
60 | 19/12/2019 14:47:41 | Female | chest infection, multinodular goiter, rt, hudronephrosis, thyrotoxicosis | co-amoxiclav | 0.625 | Oral | TDS | 2 | multinodular goiter |
60 | 19/12/2019 14:45:48 | Female | chest infection, multinodular goiter, rt, hydronephrosis, thyrotoxicosis | co-amoxiclav | 1.2 | IV | TDS | 5 | multinodular goiter |
65 | 19/12/2019 15:40:46 | Male | multiple myeloma, acute ge | co-amoxiclav | 0.6 | IV | BD | 2 | multiple myeloma |
65 | 19/12/2019 15:44:08 | Male | multiple myeloma, acute ge | levofloxacin | 0.5 | Oral | OD | 10 | multiple myeloma |
65 | 19/12/2019 15:46:01 | Male | multiple myeloma, acute ge | levofloxacin | 0.5 | IV | OD | 10 | multiple myeloma |
65 | 19/12/2019 15:47:57 | Male | multiple myeloma, acute ge | cefoperazone | 1 | IV | BD | 10 | multiple myeloma |
78 | 19/12/2019 14:09:00 | Male | severe anaemia, multiple myeloma, CKD, chest infection | co-amoxiclav | 1.2 | IV | TDS | 1 | multiple myeloma |
78 | 19/12/2019 14:10:25 | Male | severe anaemia, multiple myeloma, CKD, chest infection | clarthromycin | 0.5 | Oral | BD | 1 | multiple myeloma |
78 | 19/12/2019 14:11:59 | Male | severe anaemia, multiple myeloma, CKD, chest infection | co-amoxiclav | 0.625 | Oral | TDS | 1 | multiple myeloma |
78 | 19/12/2019 14:13:30 | Male | severe anaemia, multiple myeloma, CKD, chest infection | ceftriaxone | 1 | IV | BD | 1 | multiple myeloma |
54 | 19/12/2019 14:45:52 | Female | hydropneumothorax, empyema, type 2 dm, myoma uterus | metronidazole | 0.75 | IV | TDS | 1 | myoma uterus |
54 | 19/12/2019 14:47:44 | Female | hydropneumothorax, empyema, type 2 dm, myoma uterus | co-amoxiclav | 1.2 | IV | TDS | 14 | myoma uterus |
70 | 19/12/2019 14:04:55 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | ceftriaxone | 1 | IV | BD | 2 | neutropenia |
70 | 19/12/2019 14:05:42 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | amikacin | 0.5 | IV | BD | 8 | neutropenia |
70 | 19/12/2019 14:06:17 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | ceftazidime | 2 | IV | TDS | 2 | neutropenia |
78 | 19/12/2019 14:23:17 | Female | anteroseptal mi, klebsiella pneumonia, hypertension, type 2 dm, old stroke | co-amoxiclav | 1.2 | IV | TDS | 8 | old stroke |
87 | 19/12/2019 16:35:25 | Female | pad(lt u.l), be amputation,/post op, akt | ceftriaxone | 1 | IV | BD | 1 | pad(lt u.l) |
31 | 19/12/2019 14:50:02 | Male | pancreatitis, chronic alcoholics | ceftriaxone | 1 | IV | BD | 4 | pancreatitis |
40 | 19/12/2019 14:09:50 | Male | pcp, septic shock | co-amoxiclav | 1.2 | IV | TDS | 1 | pcp |
40 | 19/12/2019 14:10:26 | Male | pcp, septic shock | septrin | 0.96 | Oral | TDS | 1 | pcp |
31 | 19/12/2019 14:17:31 | Female | PE in distal branches of left lung pul arteries | clarithromycin | 0.5 | Oral | BD | 7 | PE in distal branches of left lung pul arteries |
31 | 19/12/2019 14:18:30 | Female | PE in distal branches of left lung pul arteries | ceftriaxone | 1 | IV | BD | 2 | PE in distal branches of left lung pul arteries |
31 | 19/12/2019 14:16:00 | Female | pe in distal bronchi of left lung pulmonary arteries | co-amoxiclav | 1.2 | IV | TDS | 10 | pe in distal bronchi of left lung pulmonary arteries |
17 | 19/12/2019 16:10:44 | Male | anaphylaxis (?penicillin) | clindamycin | 0.3 | Oral | TDS | 1 | penicillin allergy(wound infection) |
28 | 19/12/2019 13:54:08 | Female | chikungunya, rash | ceftriaxone | 1 | IV | BD | 5 | penicillin induced drug reaction |
56 | 19/12/2019 15:03:38 | Male | alcoholic hepatitis, col, he, hypokalaemia | ceftriaxone | 1 | IV | BD | 4 | periodic hypokalaemic paralysis |
58 | 19/12/2019 14:14:42 | Male | copd, piles, cva | ceftazidime | 1 | IV | TDS | 6 | piles |
35 | 19/12/2019 14:38:14 | Male | pleural effusion | co-amoxiclav | 0.625 | IV | OD | 1 | pleural effusion |
35 | 19/12/2019 14:39:24 | Male | pleural effusion | septrin | 0.96 | Oral | OD | 1 | pleural effusion |
71 | 19/12/2019 14:20:05 | Male | rvi stage 2, polyerythremia | septrin | 960 | Oral | OD | 1 | polyerythremia |
40 | 19/12/2019 16:20:07 | Male | he, col, portal hypertension, hrs, koch's lung | ceftriaxone | 1 | IV | BD | 1 | portal hypertension |
40 | 19/12/2019 16:21:01 | Male | he, col, portal hypertension, hrs, koch's lung | rifampicin | 0.55 | Oral | BD | 1 | portal hypertension |
37 | 19/12/2019 16:31:43 | Male | massive ascites, col, portal hypertension | ceftriaxone | 1 | IV | BD | 4 | portal hypertension |
37 | 19/12/2019 16:32:52 | Male | massive ascites, col, portal hypertension | septrin | 0.96 | Oral | OD | 1 | portal hypertension |
49 | 19/12/2019 14:39:20 | Female | bppv, type2 DM, postural hypertension | ceftriaxone | 1 | IV | BD | 1 | postural hypertension |
49 | 19/12/2019 14:40:19 | Female | bppv, type2 DM, postural hypertension | cefixime | 1 | Oral | BD | 5 | postural hypertension |
50 | 19/12/2019 14:40:27 | Male | treated hcv, pott’s spine | cefixime | 0.2 | Oral | BD | 5 | pott’s spine |
65 | 19/12/2019 16:22:50 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 1 | IV | TDS | 1 | pre-diabetes |
65 | 19/12/2019 16:24:34 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 0.625 | Oral | TDS | 2 | pre-diabetes |
65 | 19/12/2019 16:25:18 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | clarithromycin | 0.5 | Oral | BD | 4 | pre-diabetes |
65 | 19/12/2019 16:25:52 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | ceftriaxone | 1 | IV | BD | 2 | pre-diabetes |
49 | 19/12/2019 15:09:08 | Male | haematemesis, chronic alcoholic, he, acute gastric erosion | ceftriaxone | 1 | IV | BD | 1 | prevention of infection |
71 | 19/12/2019 15:12:17 | Female | dka, type 2 dm, ihd | ceftriaxone | 1 | IV | BD | 1 | prevention of infection |
32 | 19/12/2019 15:18:14 | Male | hepatitis, hypokalaemia, hcc, lichen amyloidosis | pentoxyfylline | 0.4 | Oral | TDS | 1 | prevention of infection |
50 | 19/12/2019 15:32:06 | Male | acute ge, pancytopenia | metronidazole | 0.75 | IV | TDS | 4 | prevention of infection |
43 | 19/12/2019 15:00:19 | Female | supine bite | amoxicillin+flucloxacillin | 0.5 | Oral | TDS | 5 | prevention of infection |
35 | 19/12/2019 15:06:44 | Female | green snake bite | amoxicillin+flucloxacillin | 0.5 | Oral | TDS | 5 | prevention of infection |
21 | 19/12/2019 15:27:01 | Male | lung abscess | co-amoxiclav | 1.2 | IV | TDS | 4 | prevention of infection |
21 | 19/12/2019 15:27:57 | Male | lung abscess | metronidazole | 0.75 | IV | TDS | 9 | prevention of infection |
21 | 19/12/2019 15:28:54 | Male | lung abscess | imipenem | 0.5 | IV | QID | 7 | prevention of infection |
73 | 19/12/2019 15:15:27 | Female | chest infection, copd | co-amoxiclav | 1.2 | IV | TDS | 1 | prevention of infection |
73 | 19/12/2019 15:16:33 | Female | chest infection, copd | clarithromycin | 0.5 | Oral | BD | 5 | prevention of infection |
17 | 19/12/2019 15:18:11 | Male | viral encephalitis, depressive d/o | ceftriaxone | 1 | IV | BD | 7 | prevention of infection |
17 | 19/12/2019 15:19:19 | Male | viral hepatitis, depressive d/o | ceftriaxone | 1 | IV | BD | 5 | prevention of infection |
52 | 19/12/2019 15:14:02 | Male | hmac nsaid induced piles gastritis | cefixime | 0.2 | Oral | BD | 5 | prevention of infection |
15 | 19/12/2019 15:14:06 | Male | avi | cefixime | 0.2 | Oral | BD | 2 | prevention of infection |
56 | 19/12/2019 15:18:37 | Male | rvi satge iv, rt-sided pleural effusion, 1st line art resistence, on anti-tb | streptomycin | 0.75 | IM | OD | 7 | prevention of infection |
56 | 19/12/2019 15:20:23 | Male | rvi satge iv, rt-sided pleural effusion, 1st line art resistence, on anti-tb | levofloxacin | 0.5 | Oral | OD | 7 | prevention of infection |
56 | 19/12/2019 15:23:06 | Male | rvi satge iv, rt-sided pleural effusion, 1st line art resistence, on anti-tb | septrin | 0.96 | Oral | OD | 7 | prevention of infection |
42 | 19/12/2019 15:27:27 | Male | stroke, newly diagnosis rvi, hbv infection | ceftriaxone | 1 | IV | BD | 1 | prevention of infection |
23 | 19/12/2019 15:32:12 | Female | acute hepatitis, clinical malaria | doxycyclin | 0.1 | Oral | BD | 7 | prevention of infection |
49 | 19/12/2019 15:35:06 | Female | pleural effusion, icm, ca breast | ceftriaxone | 1 | IV | BD | 1 | prevention of infection |
55 | 19/12/2019 15:39:34 | Female | chest infection, dm, ckd, traction retinal detachment | co-amoxiclav | 0.6 | IV | BD | 7 | prevention of infection |
22 | 19/12/2019 15:04:18 | Female | chikangunya | azithromycin | 0.5 | Oral | OD | 5 | fever |
45 | 19/12/2019 15:21:36 | Female | skin infection, staphylococcal infection, tb | levefloxacin | 0.5 | IV | OD | 5 | fever |
32 | 19/12/2019 15:30:42 | Male | prolonged fever ē, hypotension(leptospirosis) | ceftriaxone | 1 | IV | BD | 4 | fever |
45 | 19/12/2019 15:19:24 | Female | skin infection, staphylococcal infection, tb | amoxicillin+flucoxacillin | 1 | IV | QID | 1 | fever |
45 | 19/12/2019 15:20:20 | Female | skin infection, staphylococcal infection, tb | metronidazole | 0.75 | IV | TDS | 11 | fever |
50 | 19/12/2019 16:27:17 | Male | thyrotoxicosis, joint pain, puo | ceftriaxone | 1 | IV | BD | 4 | puo |
18 | 19/12/2019 13:57:12 | Male | pyexia of unknown origin | ceftriaxone | 1 | IV | BD | 2 | pyexia of unknown origin |
45 | 19/12/2019 15:28:11 | Female | recurrent uti, type 2 dm | meropenem | 500 | IV | TDS | 4 | uti |
52 | 19/12/2019 14:37:18 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | septrin | 0.96 | Oral | OD | 1 | renal impairment |
52 | 19/12/2019 14:38:22 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | coamoxiclav | 0.6 | IV | OD | 5 | renal impairment |
52 | 19/12/2019 14:39:09 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | co-amoxiclav | 1.2 | IV | BD | 2 | renal impairment |
43 | 19/12/2019 14:56:32 | Male | acute severe asthma | co-amoxiclav | 1.2 | IV | TDS | 1 | respiratory infection |
32 | 19/12/2019 16:14:45 | Female | general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+) | co-amoxiclav | 1.2 | IV | TDS | 2 | retro(+) |
32 | 19/12/2019 16:15:20 | Female | general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+) | co-amoxiclav | 0.6 | Oral | OD | 2 | retro(+) |
32 | 19/12/2019 16:17:20 | Female | general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+) | septrin | 0.96 | Oral | OD | 1 | retro(+) |
35 | 19/12/2019 15:19:59 | Female | rheumatic heart disease with atrial flutter | pen v | 0.25 | Oral | QID | 7 | rheumatic fever |
42 | 19/12/2019 14:59:14 | Female | acute ge, rhd( severe ms mild mr) e af on warfrin | cifran | 0.75 | IV | BD | 3 | rheumatic heart disease |
42 | 19/12/2019 15:04:50 | Female | acute ge, rhd(severe ms mild mr) e af on warfrin | metronidazole | 0.75 | IV | TDS | 3 | rheumatic heart disease |
42 | 19/12/2019 15:06:14 | Female | acute ge, rhd(severe ms mild mr) e af on warfrin | pen v | 0.25 | Oral | BD | 3 | rheumatic heart disease |
69 | 19/12/2019 14:04:40 | Female | gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg | metronidazole | 0.75 | IV | TDS | 5 | right cerebral infarct |
69 | 19/12/2019 14:08:30 | Female | gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg | cefipime | 1 | IV | BD | 1 | right cerebral infarct |
29 | 19/12/2019 14:51:40 | Female | right lobe consolidation chest infection, thrombocytopenia | clarithromycin | 0.5 | Oral | BD | 5 | right lobe consolidation |
29 | 19/12/2019 14:47:30 | Female | right lower lobe consolidation chest infection, thrombocytopenia | co-amoxiclav | 0.625 | Oral | TDS | 3 | right lower lobe consolidation |
38 | 19/12/2019 14:50:17 | Male | right sided hemiplegia, uncontrolled dm, chronic pancreatitis, chronix diarrhoea | ceftriaxone | 1 | IV | BD | 2 | right sided hemiplegia |
60 | 19/12/2019 14:47:41 | Female | chest infection, multinodular goiter, rt, hudronephrosis, thyrotoxicosis | co-amoxiclav | 0.625 | Oral | TDS | 2 | rt |
60 | 19/12/2019 14:45:48 | Female | chest infection, multinodular goiter, rt, hydronephrosis, thyrotoxicosis | co-amoxiclav | 1.2 | IV | TDS | 5 | rt |
31 | 19/12/2019 14:30:33 | Female | rvi, stage4, art noise, hepatitis, bone marrow depression | cefipime | 1 | IV | BD | 4 | rvi |
48 | 19/12/2019 15:37:12 | Female | he, rvi with col | ceftriaxone | 1 | IV | OD | 8 | rvi |
48 | 19/12/2019 15:40:22 | Female | he, rvi with col | levofloxacin | 0.25 | IV | OD | 3 | rvi |
48 | 19/12/2019 15:34:56 | Female | he, rvi with col | ceftriaxone | 1 | IV | BD | 8 | rvi |
48 | 19/12/2019 15:38:59 | Female | he, rvi with col | levofloxacin | 0.5 | IV | OD | 8 | rvi |
71 | 19/12/2019 14:20:05 | Male | rvi stage 2, polyerythremia | septrin | 960 | Oral | OD | 1 | rvi |
52 | 19/12/2019 14:37:18 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | septrin | 0.96 | Oral | OD | 1 | rvi |
52 | 19/12/2019 14:38:22 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | coamoxiclav | 0.6 | IV | OD | 5 | rvi |
52 | 19/12/2019 14:39:09 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | co-amoxiclav | 1.2 | IV | BD | 2 | rvi |